Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Quinazolinone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102898385B reveals a recyclable CuO catalyzed route for 2-arylquinazolinones, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Advanced synthesis of fluorinated quinazolinone-triazole hybrids via patent CN103059001A. Offers high purity, scalable routes, and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN103819414B enables green aqueous synthesis of quinazolinones. Reduces solvent costs and improves supply chain reliability for pharmaceutical intermediate manufacturing globally.
Patent CN114644655B reveals a green photocatalytic route for quinazolinone derivatives. This method offers significant supply chain reliability and cost reduction advantages for pharmaceutical manufacturing.
Novel one-step method for quinazolinone derivatives offers high yield and green chemistry advantages for pharmaceutical supply chains.
Patent CN104710368B reveals high-yield Pd-catalyzed route for quinazolinone intermediates. Delivers supply chain stability and cost efficiency for pharmaceutical manufacturing.
Patent CN111592549B reveals a novel Rh-catalyzed [4+1] cyclization for quinazolinone derivatives, offering streamlined synthesis and cost reduction in API manufacturing.
Advanced synthetic method for quinazolinone intermediates offering high yield and mild conditions. Ideal for pharmaceutical supply chain optimization and cost reduction.
Patent CN119143756A enables green photocatalytic synthesis. Offers significant cost reduction and scalable supply chain solutions for high-purity antiviral pharmaceutical intermediates globally.
Novel C-H activation method for spiro quinazolinones offers high yield and scalability for reliable pharmaceutical intermediate supply chains.
Patent CN113045503A reveals a novel palladium-catalyzed carbonylation route for 2-trifluoromethyl quinazolinones, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Patent CN112480015B reveals a novel Pd-catalyzed one-pot method for synthesizing 2-trifluoromethyl quinazolinones, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Novel Pd-catalyzed carbonylation route for 2-CF3 quinazolinones. High yield, scalable process for API intermediates like Rutaecarpine.
Patent CN113045503A reveals a robust palladium-catalyzed route for 2-trifluoromethyl quinazolinones, offering superior yields and scalability for API manufacturing.
Patent CN112480015B reveals a mild one-pot synthesis for 2-trifluoromethyl quinazolinones, offering cost reduction in API manufacturing and reliable supply chain solutions.
Novel Pd-catalyzed carbonylation method for quinazolinones. High yield, scalable route for drug molecules like Rutaecarpine.
Novel Pd-catalyzed carbonylation method for 2-CF3 quinazolinones. High yield, scalable route for API intermediates like Rutaecarpine.
Novel FeCl3-catalyzed route offers high yield and scalability for drug intermediates, reducing costs in API manufacturing.
Patent CN111675662B reveals a novel iron-catalyzed route for 2-trifluoromethyl quinazolinones, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN112480015B reveals a novel one-pot Pd-catalyzed method for synthesizing 2-trifluoromethyl quinazolinones, offering significant cost reduction in API manufacturing and high purity.